|
|
Volumn 11, Issue 11, 2005, Pages 754-755
|
|
The outlook for peptide drugs and the intricate relationship beween the Active Pharmaceutical Ingredients manufacturer and their sponsors
a
|
|
Author keywords
Active Pharmaceutical Ingredients manufacturing; Peptide drug; Production scale up
|
|
Indexed keywords
DESMOPRESSIN;
ENFUVIRTIDE;
LEUPRORELIN;
PEPTIDE DERIVATIVE;
PRAMLINTIDE;
SALCATONIN;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG SAFETY;
DRUG TARGETING;
GOOD MANUFACTURING PRACTICE;
HUMAN;
NOTE;
PRIORITY JOURNAL;
SCALE UP;
SIDE EFFECT;
DRUG DESIGN;
DRUG INDUSTRY;
PEPTIDES;
|
|
EID: 28044446118
PISSN: 10752617
EISSN: None
Source Type: Journal
DOI: 10.1002/psc.718 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
